Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort study

Azvudine has been designated as a priority treatment for patients infected with SARS-CoV-2, however, clinical evidence in hospitalized cases remains insufficient. We performed a multi-center, retrospective cohort study to evaluate the effectiveness and safety of azvudine in hospitalized patients wit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infection 2024-12, Vol.89 (6), p.106355, Article 106355
Hauptverfasser:	Ren, Zhigang, Yang, Mengzhao, Su, Guanyue, Qian, Guowu, Yuan, Yiqiang, Yu, Jia, Li, Silin, Wang, Changshuang, Lu, Mingxia, Luo, Hong, Zhang, Shixi, Li, Guangming, Zhang, Donghua, Wang, Ling, Li, Guotao, Jin, Xiaoli, Wang, Juan, Wang, Mingming, Cheng, Ming, Wang, Haiyu, Chang, Junbiao, Yu, Zujiang
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged All-cause death Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Azvudine China - epidemiology Composite disease progression COVID-19 - mortality COVID-19 Drug Treatment Disease Progression Female Hospitalization - statistics & numerical data Humans Male Middle Aged Real-world Retrospective Studies SARS-CoV-2 Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!